1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Chronic Disease Market Trends
  5. > Chronic Disease Analysis & Statistics

Chronic Disease Analysis & Statistics

1-30 of about 200 reports

Consumer Values and Behaviour in Poland

  • $ 1325
  • November 2021
  • 57 pages

This report visually explores everyday habits and behaviours that reflect consumers’ beliefs and values, linking behavioural trends with purchase and consumption habits in Poland. Consumer Values ...

  • Poland
  • Leisure
  • Pollution Control
  • Industry analysis

Milk Allergies and the Rise of Non-Cow Dairy

  • $ 1325
  • March 2021
  • 23 pages

Milk allergies continue to be a growing condition among consumers globally. This report analyses key drivers behind the following of dairy-free diets, the opportunities for more easily digestible options, ...

  • United States
  • France
  • Food Allergy
  • Allergy
  • Industry analysis
  • Allergy Prevalence
  • Dairy Products Consumption

Qatar in 2040: The Future Demographic

  • $ 990
  • November 2021
  • 17 pages

Qatar’s population will expand in 2021-2040 as a result of natural increase and a resumption of positive net migration, after a decline in 2020-2021 as many foreign workers left the country due to the ...

  • Qatar
  • Diabetes
  • Healthcare
  • Country analysis
  • Net Migration Rate
  • Life Expectancy

Cough, Cold and Allergy (Hay Fever) Remedies in Germany

  • $ 990
  • November 2021
  • 26 pages

With requirements to wear protective face masks in public spaces indoors in addition to some outdoor settings in Germany in 2021, the transmission of viruses in general, including influenza, has consequently ...

  • Germany
  • Allergy
  • Hay
  • Industry analysis
  • Health Insurance Claims
  • Life Expectancy

Cough, Cold and Allergy (Hay Fever) Remedies in Lithuania

  • $ 990
  • November 2021
  • 24 pages

Cough, cold and allergy (hay fever) remedies continues to see a sharp deceleration in retail value sales growth during 2021 due to the impact of COVID-19. Indeed, cough, cold and allergy (hay fever) remedies ...

  • Lithuania
  • OTC
  • Hay
  • Industry analysis
  • Health Insurance Claims
  • Life Expectancy

Cough, Cold and Allergy (Hay Fever) Remedies in Switzerland

  • $ 990
  • November 2021
  • 26 pages

Cough, cold and allergy (hay fever) remedies registered positive sales growth in 2021 as the impact of the COVID-19 pandemic continued to wane. However, sales growth remained very moderate as most consumers ...

  • Switzerland
  • Hay
  • Allergy
  • Industry analysis
  • Online Retail Sales
  • Life Expectancy

Belgium in 2040: The Future Demographic

  • $ 990
  • October 2021
  • 17 pages

Relatively strong rates of net migration will drive population expansion of 3.4% in Belgium in 2020-2040, despite natural change being negative over this timeframe. Ageing is set to accelerate impacting ...

  • Belgium
  • Healthcare
  • Diabetes
  • Country analysis
  • Net Migration Rate
  • Life Expectancy

Cough, Cold and Allergy (Hay Fever) Remedies in Cameroon

  • $ 990
  • October 2021
  • 22 pages

In 2021, seasonal colds and the flu will continue to be the main drivers of growth for cough, cold and allergy (hay fever remedies) in Cameroon. Increased sales in value and volume terms were recorded ...

  • Cameroon
  • OTC
  • Hay
  • Industry analysis
  • Disposable Income
  • Life Expectancy

Cough, Cold and Allergy (Hay Fever) Remedies in Uruguay

  • $ 990
  • October 2021
  • 24 pages

Coronavirus (COVID-19) measures like social distancing, mask wearing and regular hand washing, and higher flu vaccination rates have continued to diminish the spread of influenza and colds in 2021. As ...

  • Uruguay
  • OTC
  • Allergy
  • Industry analysis
  • Vaccination Coverage
  • Online Retail Sales

Cough, Cold and Allergy (Hay Fever) Remedies in North Macedonia

  • $ 990
  • October 2021
  • 24 pages

Over the review period, cough, cold and allergy (hay fever) remedies benefited from the self-medication trend in North Macedonia. Nonetheless, as a result of the COVID-19 lockdowns and mandated mask wearing, ...

  • Macedonia
  • Allergy
  • Hay
  • Industry analysis
  • Retail Revenue
  • Life Expectancy

Cough, Cold and Allergy (Hay Fever) Remedies in Tunisia

  • $ 990
  • October 2021
  • 21 pages

A growing number of Tunisians are suffering from allergies, given that the country is characterised by increasing pollution and declining air quality. Seasonal variations in pollution exist, with the highest ...

  • Tunisia
  • OTC
  • Hay
  • Industry analysis
  • Household Consumption Expenditure
  • Life Expectancy

Cough, Cold and Allergy (Hay Fever) Remedies in Hong Kong, China

  • $ 990
  • October 2021
  • 25 pages

Cough, cold and allergy (hay fever) remedies is expected to register a mild recovery in 2021 following the significant losses of 2020. With tourist spending having accounted for a significant share of ...

  • Hong Kong
  • China
  • Hay
  • Allergy
  • Industry analysis
  • Life Expectancy
  • Pharmaceutical Registrations

Cough, Cold and Allergy (Hay Fever) Remedies in Pakistan

  • $ 990
  • October 2021
  • 23 pages

Cough, cold and allergy (hay fever) remedies is a sizeable product area in Pakistan, compared with other consumer health products. In fact, it is the largest product area in terms of value sales, posting ...

  • Pakistan
  • Hay
  • Allergy
  • Industry analysis
  • Life Expectancy
  • Analgesic Medicine Sales

Cough, Cold and Allergy (Hay Fever) Remedies in Uzbekistan

  • $ 990
  • October 2021
  • 22 pages

Sales of cough, cold and allergy (hay fever) remedies are stimulated by the event of COVID-19 in 2021, as such products are aimed at some of the key symptoms of the virus and consumers continue to keep ...

  • Uzbekistan
  • OTC
  • Hay
  • Industry analysis
  • Life Expectancy
  • Vitamin Import

Cough, Cold and Allergy (Hay Fever) Remedies in Serbia

  • $ 990
  • October 2021
  • 24 pages

Cough, cold and allergy (hay fever) remedies is expected to record slower declines in retail volume and current value sales over 2021, compared with 2020. The slump in sales in a hitherto strong performing ...

  • Serbia
  • OTC
  • Hay
  • Industry analysis
  • Life Expectancy
  • Labour Force

Cough, Cold and Allergy (Hay Fever) Remedies in Hungary

  • $ 990
  • October 2021
  • 26 pages

Cough, cold and allergy (hay fever) remedies did not register the same explosive growth as analgesics in 2020, with value sales on a par or even lower than pre pandemic times. The same is expected to occu ...

  • Hungary
  • Hay
  • Allergy
  • Industry analysis
  • Online Retail Sales
  • Life Expectancy

Cough, Cold and Allergy (Hay Fever) Remedies in Indonesia

  • $ 990
  • October 2021
  • 23 pages

Overall cough, cold and allergy (hay fever) remedies is accelerating slightly in value growth terms compared with 2020 due to home seclusion. Because consumers would like to avoid visiting public places ...

  • Indonesia
  • Hay
  • Allergy
  • Industry analysis
  • Outpatient Visits
  • Life Expectancy

Cough, Cold and Allergy (Hay Fever) Remedies in Dominican Republic

  • $ 990
  • October 2021
  • 23 pages

The biggest trends in cough, cold and allergy (hay fever) remedies in 2021 are development-focused. In particular, there have been innovations in products which do not cause drowsiness and medicines which ...

  • Dominican Republic
  • Hay
  • Allergy
  • Industry analysis
  • Life Expectancy

Cough, Cold and Allergy (Hay Fever) Remedies in Kenya

  • $ 990
  • October 2021
  • 23 pages

With the rise of the COVID-19 pandemic, most Kenyans have taken a keen interest in trying to boost their immunity by ingesting foods rich in vitamin C, including oranges and lemons. Consumers have also ...

  • Kenya
  • Allergy
  • Hay
  • Industry analysis
  • Health Insurance Claims
  • Life Expectancy

Cough, Cold and Allergy (Hay Fever) Remedies in Brazil

  • $ 990
  • October 2021
  • 27 pages

Cough, cold and allergy (hay fever) remedies saw a notable fall in current value terms in 2020, due to social distancing and the usage of masks, which limited the chance of infection, although stockpiling ...

  • Brazil
  • Hay
  • Allergy
  • Industry analysis
  • Prescription Drug Sales
  • Health Insurance Claims

Cough, Cold and Allergy (Hay Fever) Remedies in Israel

  • $ 990
  • October 2021
  • 24 pages

Cough and cold remedies suffered a dramatic slump in value sales in 2020, as lockdowns and social distancing measures curbed the spread of the common cold. With society opening up for the most part is ...

  • Israel
  • Allergy
  • Hay
  • Industry analysis
  • Life Expectancy
  • Vaccination Coverage

Cough, Cold and Allergy (Hay Fever) Remedies in Morocco

  • $ 990
  • October 2021
  • 24 pages

With society learning to live with the threat of COVID-19, consumers stop stockpiling and as a result, current value growth for cough, cold and allergy (hay fever) remedies is expected to be lower in 2021. ...

  • Morocco
  • OTC
  • Hay
  • Industry analysis
  • Pharmaceutical Production
  • Life Expectancy

Cough, Cold and Allergy (Hay Fever) Remedies in Portugal

  • $ 990
  • October 2021
  • 25 pages

Portugal introduced a strict lockdown from January to April 2021 due to a major wave of COVID-19. The lockdown, combined with ongoing social distancing measures and new more stringent hygiene habits such ...

  • Portugal
  • Hay
  • Allergy
  • Industry analysis
  • Online Retail Sales
  • Life Expectancy

Cough, Cold and Allergy (Hay Fever) Remedies in Guatemala

  • $ 990
  • October 2021
  • 22 pages

Prior to the pandemic, there was a growing trend for more natural options which led major players to add natural ingredients to their offerings, such as Afrin Pure Sea which is a nasal spray that uses ...

  • Guatemala
  • OTC
  • Allergy
  • Industry analysis
  • Life Expectancy
  • Prescription Drug Sales

Cough, Cold and Allergy (Hay Fever) Remedies in Slovenia

  • $ 990
  • October 2021
  • 24 pages

In 2021, decongestants is expected to see a moderate rebound from strong declines in retail volume and current value sales in 2020. Stringent Coronavirus (COVID-19) lockdown measures, such as mask-wearing, ...

  • Slovenia
  • OTC
  • Allergy
  • Industry analysis
  • Birth Rate
  • Disposable Income

Cough, Cold and Allergy (Hay Fever) Remedies in Latvia

  • $ 990
  • October 2021
  • 23 pages

Cough, cold and allergy (hay fever) remedies will see even stronger current value declines in 2021 as COVID-19 measures reduce the potential of catching common colds. Such measures include lockdown restrictions ...

  • Latvia
  • OTC
  • Allergy
  • Industry analysis
  • Life Expectancy
  • Online Expenditure

Cough, Cold and Allergy (Hay Fever) Remedies in Kazakhstan

  • $ 990
  • October 2021
  • 26 pages

Cough, cold and allergy (hay fever) remedies will record a steep decline in total current value sales in 2021, with all categories expected to see volume sales fall sharply. This is partly the result of ...

  • Kazakhstan
  • Hay
  • Allergy
  • Industry analysis
  • Online Retail Sales
  • Life Expectancy

Cough, Cold and Allergy (Hay Fever) Remedies in Azerbaijan

  • $ 990
  • October 2021
  • 24 pages

Sales of cough, cold and allergy (hay fever) remedies dropped in 2020, as restrictions on social distancing, the shutdown of schools and other quarantine measures in response to the pandemic reduced the ...

  • Azerbaijan
  • Allergy
  • Hay
  • Industry analysis
  • Disposable Income
  • Life Expectancy

Cough, Cold and Allergy (Hay Fever) Remedies in Belarus

  • $ 990
  • October 2021
  • 22 pages

COVID-19 continues to stimulate sales of cough and cold remedies in Q1 and Q2 of 2021, as consumers remain cautious and begin treatment as soon as the first symptoms occur. The highest demand is in cough ...

  • Belarus
  • Allergy
  • Hay
  • Industry analysis
  • Over The Counter Drug Sales
  • Online Retail Sales

Cough, Cold and Allergy (Hay Fever) Remedies in the US

  • $ 990
  • October 2021
  • 29 pages

Following exceptionally strong demand for cold remedies in the first half of 2020, the residual effects of stockpiling, combined with a soft cold and flu season, led to a significant decline in sales of ...

  • United States
  • Allergy
  • Hay
  • Industry analysis
  • Drug Approval
  • Life Expectancy
About 24000 reports

Download Unlimited Documents from Trusted Public Sources

View report >

Respiratory Disease Sales Statistics in Nigeria

  • January 2022
  • 10 pages
  • Nigeria
  • West Africa
  • Infectious Disease
  • Respiratory Disease
  • Industry analysis
  • Infectious Disease Mortality
  • Maternal Mortality Rate

Peru Economic Analysis January 2022


Reportlinker.com © Copyright 2022. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on